Freestone Grove Partners LP Makes New Investment in National Health Investors, Inc. $NHI

Key Points

• Freestone Grove Partners acquired 30,673 shares of National Health Investors worth approximately $2.34 million, while institutional investors collectively own 62.51% of the REIT.
• NHI insiders also bought shares, including 890 shares purchased by Director Robert A. McCabe Jr. and 1,500 shares bought by CEO D. Eric Mendelsohn.
• Analysts maintain a consensus “Moderate Buy” rating with an average price target of $83.86. The company reported $1.19 in quarterly EPS and declared a $0.92 quarterly dividend, representing a 5.1% annualized yield.

Freestone Grove Partners LP bought a new stake in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 30,673 shares of the real estate investment trust's stock, valued at approximately $2,339,000. Freestone Grove Partners LP owned 0.06% of National Health Investors as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. International Assets Investment Management LLC bought a new stake in shares of National Health Investors during the 4th quarter valued at about $27,000. EverSource Wealth Advisors LLC lifted its stake in shares of National Health Investors by 244.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust's stock valued at $28,000 after buying an additional 288 shares in the last quarter. Garton & Associates Financial Advisors LLC bought a new position in shares of National Health Investors in the fourth quarter worth about $33,000. Allworth Financial LP purchased a new stake in National Health Investors during the 2nd quarter valued at approximately $42,000. Finally, Advisory Services Network LLC purchased a new position in National Health Investors during the third quarter valued at $65,000. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at National Health Investors

In other news, Director Robert A. Mccabe, Jr. bought 890 shares of the firm's stock in a transaction that occurred on Monday, June 15th. The stock was purchased at an average cost of $71.65 per share, for a total transaction of $63,768.50. Following the purchase, the director directly owned 44,159 shares in the company, valued at approximately $3,163,992.35. This trade represents a 2.06% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of the stock in a transaction dated Friday, June 5th. The shares were purchased at an average cost of $68.84 per share, for a total transaction of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This represents a 1.14% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 2.70% of the company's stock.

Analysts Set New Price Targets

NHI has been the topic of a number of research reports. Truist Financial reduced their price objective on National Health Investors from $89.00 to $81.00 and set a "buy" rating on the stock in a research note on Friday, June 12th. Wells Fargo & Company dropped their target price on National Health Investors from $84.00 to $79.00 and set an "equal weight" rating for the company in a research report on Monday, June 1st. Deutsche Bank Aktiengesellschaft reduced their price target on shares of National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research note on Thursday, June 25th. BMO Capital Markets dropped their price target on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a research report on Monday, June 15th. Finally, Weiss Ratings downgraded shares of National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research note on Friday, June 12th. Five analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, National Health Investors presently has a consensus rating of "Moderate Buy" and an average target price of $83.86.

National Health Investors Stock Down 0.8%

National Health Investors stock opened at $71.96 on Friday. National Health Investors, Inc. has a fifty-two week low of $67.94 and a fifty-two week high of $91.38. The business's 50-day simple moving average is $75.68 and its two-hundred day simple moving average is $78.76. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The company has a market cap of $3.53 billion, a PE ratio of 20.80, a PEG ratio of 3.86 and a beta of 0.51.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $1.19 EPS for the quarter. The business had revenue of $121.32 million during the quarter. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The business's revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.22 earnings per share. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. Equities analysts anticipate that National Health Investors, Inc. will post 4.78 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be issued a $0.92 dividend. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.68 dividend on an annualized basis and a yield of 5.1%. National Health Investors's payout ratio is presently 106.36%.

National Health Investors Profile

National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source